including alcohol or illicit drugs such cocaine; chemotherapy- induced cardiomyopathies (e.g., Adriamycin); myocarditis and viral cardiomyopathy; postpartum cardiomyopathy; tachycardia-mediated HF; infiltrative disorders, such as sarcoidosis, hemochromatosis, and amyloidosis; high-output states; and stress...
Tafamidis is the first medication approved for the treatment of ATTR–C. The landmark ATTRACT trial showed a reduction in cardiovascular mortality and cardiovascular–related hospitalization in patients treated with tafamidis compared to placebo. From October 2021 tafamidis can be prescribed in Italy ...
Purpose of review;Cardiac amyloidosis, an infiltrative restrictive cardiomyopathy once thought to be universally fatal, is now increasingly recognized as less rare than previously thought. This update is intended to provide a review of newer aspects of the presentation, diagnosis and treatment of cardia...
High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac Amyloidosis No drug interventions diagnostic Not Available unknown_status NCT00568165 EMEPIC : Value of a Mobile Team of Cardiologist Using Echocardiography for Managing Patients With Acute Heart Failure No dru...
Autonomic dysfunction- usually a symptom of another degenerative disease such as Parkinson disease, multiple system atrophy, Lewy body dementia or can be a primary disease on its own; can also occur as a direct result of diabetes, amyloidosis, and spinal cord trauma ...
Physicians should be more cautious when administering medication potentially cardiotoxic to patients undertaking osimertinib. Routine surveillance of ECG and UCG for cardiac adverse events is also necessary during osimertinib treatment. The guideline or expert consensus for the diagnosis and treatment of ...
months because of worsening renal function and diarrhea, both known adverse effects of this medication. He was intermittently treated with metolazone 5?mg po QD for enhanced diuresis and on various degrees of β‐blockade as hemodynamically tolerated. He was subsequently referred to our center for ...
The 5-day period included both patients with and without COVID-19 receiving treatment with hydroxychloroquine and/or azithromycin (with proper pharmacy documentation) and patients receiving neither medication. A baseline ECG was defined as the initial ECG within 48 hours of hospital admission. The ...
Hamon from Créteil and other French centers267 found that patients with cardiac amyloidosis and ICD implantation (84% for primary prevention) had at least 1 appropriate ICD therapy in 27% of the population after a mean follow-up of 5 months. No specific factors associated with ICD therapy were...
There are current clinical trials of medication that will try to actively take the amyloid out of the heart, but they're not yet approved. However, Dr. Grogan says the future looks bright. "These new medications are very exciting. In fact, that area of amyloidosis research is truly an exp...